Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma-Reference-Cited by-同舟云学术

Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma

Published:2017-11-21 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Liu Xiaolin¹,Nie Weiwei¹,Xie Qi²,Chen Guoling³,Li Xingyu¹,Jia Yanrui¹,Yin Beibei¹,Qu Xun⁴,Li Yan¹,Liang Jing¹

Affiliation:

1. Department of Oncology, Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China

2. Medical Research Center, Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China

3. Islet Cell Laboratory, MedStar Georgetown University Hospital, Washington, DC 20007, USA

4. Institute of Basic Medical Sciences and Key Laboratory of Cardiovascular Proteomics of Shandong Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta-analysis of recombinant human endostatin combined with NP regimen for treating non-small cell lung cancer;Medicine;2024-05-24

2. RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression;Anticancer Research;2023-09-29

3. Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis;International Immunopharmacology;2023-08

4. The extracellular microenvironment in immune dysregulation and inflammation in retinal disorders;Frontiers in Immunology;2023-03-01

5. Current status of and progress in the treatment of malignant pleural effusion of lung cancer;Frontiers in Oncology;2023-01-20